RETRACTION: MiR-625-5p/PKM2 Negatively Regulates Melanoma Glycolysis State

被引:0
|
作者
Zhang, H.
Feng, C.
Zhang, M.
Zeng, A.
Si, L.
Yu, N.
Bai, M.
机构
关键词
D O I
10.1002/jcb.30651
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RETRACTION: H. Zhang, C. Feng, M. Zhang, A. Zeng, L. Si, N. Yu, and M. Bai, "MiR-625-5p/PKM2 Negatively Regulates Melanoma Glycolysis State," Journal of Cellular Biochemistry 120, no. 3 (2019): 2964-2972, . The above article, published online on 30 November 2018 in Wiley Online Library (), has been retracted by agreement between the authors; the journal Editor-in-Chief, Christian Behl; and Wiley Periodicals LLC. The authors requested a retraction of this manuscript stating that different cell lines were wrongly labelled and that the conclusions of this manuscript needed to be re-evaluated. Further investigation by the publisher revealed that the article mentions use of the non-verifiable/unknown normal skin cells HFE. Additional flaws and inconsistencies between results presented and experimental methods described were identified. Furthermore, the experimental methods were found to lack sufficient details or have unavailable supporting data, making the experiments not comprehensible nor reproducible to readers. Accordingly, the editors consider the conclusions of this article to be invalid.
引用
收藏
页数:1
相关论文
共 50 条
  • [1] miR-625-5p/PKM2 negatively regulates melanoma glycolysis state
    Zhang, Hailin
    Feng, Cheng
    Zhang, Mingzi
    Zeng, Ang
    Si, Loubin
    Yu, Nanze
    Bai, Ming
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 2964 - 2972
  • [2] MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma
    Chen, Jianan
    Yu, Yan
    Chen, Xiaolong
    He, Yuting
    Hu, Qiuyue
    Li, Hongqiang
    Han, Qicai
    Ren, Fang
    Li, Juan
    Li, Chao
    Bao, Jie
    Ren, Zhigang
    Duan, Zhenfeng
    Cui, Guangying
    Sun, Ranran
    CELL PROLIFERATION, 2018, 51 (06)
  • [3] Overexpressed miR-122-5p Promotes Cell Viability, Proliferation, Migration And Glycolysis Of Renal Cancer By Negatively Regulating PKM2
    Wang, Shuai
    Zheng, Wei
    Ji, Alin
    Zhang, Dahong
    Zhou, Mi
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9701 - 9713
  • [4] MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis
    Yu, Tianzhu
    Li, Guoping
    Wang, Chenggang
    Gong, Gaoquan
    Wang, Liangwen
    Li, Changyu
    Chen, Yi
    Wang, Xiaolin
    RNA BIOLOGY, 2021, 18 (12) : 2513 - 2530
  • [5] The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma
    He Xiaoyu
    Yin Yiru
    Shi Shuisheng
    Cheng Keyan
    Yan Zixing
    Cheng Shanglin
    Wang Yuan
    Cheng Dongming
    Zhang Wangliang
    Bai Xudong
    Ma Jie
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2018, 17
  • [6] miR-491-5p inhibits osteosarcoma cell proliferation by targeting PKM2
    Chen, Ting
    Li, Yuyang
    Cao, Wenliang
    Liu, Yadong
    ONCOLOGY LETTERS, 2018, 16 (05) : 6472 - 6478
  • [7] Hypoxia-associated circDENND2A promotes glioma aggressiveness by sponging miR-625-5p
    Hui Su
    Defei Zou
    Yikun Sun
    Yiwu Dai
    Cellular & Molecular Biology Letters, 2019, 24
  • [8] Hypoxia-associated circDENND2A promotes glioma aggressiveness by sponging miR-625-5p
    Su, Hui
    Zou, Defei
    Sun, Yikun
    Dai, Yiwu
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2019, 24 (1)
  • [9] Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis
    Xu, Qiuran
    Dou, Changwei
    Liu, Xin
    Yang, Liu
    Ni, Chao
    Wang, Jiahui
    Guo, Yang
    Yang, Wei
    Tong, Xiangmin
    Huang, Dongsheng
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 1692 - 1704
  • [10] Dihydroartemisinin Regulates Self-Renewal of Human Melanoma-Initiating Cells by Targeting PKM2/LDHA-Related Glycolysis
    Li, Zhen
    Zeng, Baozhen
    Wang, Baoqing
    Xiao, Yanbin
    Ma, Xiang
    Liu, Zhimin
    Wang, Jianqiang
    Dong, Suwei
    EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY, 2024, 8 (02): : 225 - 232